Altimmune, Inc. (ALT)
4.86
+0.24
(+5.19%)
USD |
NASDAQ |
Jan 22, 10:40
Altimmune Market Cap: 507.10M for Jan. 22, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Viking Therapeutics, Inc. | 3.864B |
| CorMedix, Inc. | 589.34M |
| Actinium Pharmaceuticals, Inc. | 42.43M |
| Aldeyra Therapeutics, Inc. | 312.24M |
| Seres Therapeutics, Inc. | 135.17M |
Market Cap Related Metrics
| PS Ratio | 19300.52 |
| Price to Book Value | 2.732 |
| Price | 4.86 |
| Earnings Yield | -21.99% |